Total Count 23

JAMJOOM PHARMA - Argaam Reports

Major events set to drive performance of Saudi-listed firms in Q3 2025

Argaam Special 12/10/2025

How did analysts view Jamjoom Pharma Q2 2025 financials?

Argaam Special 25/08/2025

Rundown of Jamjoom Pharma's financials, operating segments in Q2 2025

Argaam Special 10/08/2025

Jamjoom Pharma reviews 2025-2027 guidance

Argaam Special 27/07/2025

Ranked: Tadawul's 50 most profitable companies in Q1 2025

Argaam Special 26/05/2025

How did analysts view Jamjoom Pharma Q1 2025 financials?

Argaam Special 14/05/2025

Jamjoom Pharma revises guidance for next 3 years 

Argaam Special 30/04/2025

Highest-paid executives, board members of Saudi-listed firms in 2024

Argaam Special 21/04/2025

Analyst ratings, average TP for Jamjoom Pharma post-Q3 2024

Argaam Special 23/12/2024

Jamjoom Pharma maintains 2024 guidance

Argaam Special 27/10/2024

What do analysts expect from Jamjoom Pharma's Q3 2024 results?

Argaam Special 24/10/2024

Key events forecast to impact Saudi-listed firms’ earnings in Q3 2024

Argaam Special 06/10/2024

How analysts rated Jamjoom Pharma after Q2 results?

Argaam Special 11/09/2024

Analyst forecasts on Jamjoom Pharma Q2 2024 profit

Argaam Special 05/08/2024

Key events likely to impact Saudi-listed firms’ earnings in Q2 2024

Argaam Special 04/07/2024

Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023

Argaam Special 21/04/2024

Jamjoom Pharma seen to post profit growth in Q4 2023

Argaam Special 20/02/2024

How did analysts view TASI performance, top picks for 2024?

Argaam Special 09/01/2024

How did analysts view Jamjoom Pharma’s Q3 financials?

Argaam Special 05/12/2023

Jamjoom Pharma revises up 2023 guidance

Argaam Special 10/08/2023